Navigation Links
Book: 'Synthetic Biology and Morality'
Date:9/12/2013

Synthetic biology aims to design and build organisms to serve human ends, such as producing inexpensive biofuels and developing new kinds of medicines. But this new form of biotechnology also raises ethical questions. The concerns range from environmental and public health risks to social and economic impact, but perhaps the foremost is, Should we be "creating life" in the first place?

The last question is explored in Synthetic Biology and Morality: Artificial Life and the Bounds of Nature, a collection of essays edited by Hastings Center scholars Gregory E. Kaebnick and Thomas H. Murray, just published by MIT Press.

"Synthetic biology seems to involve a quest for a degree of control over the basic mechanisms of life that human beings have never attained before; is that quest desirable? Is it troubling?" write Kaebnick and Murray in the introduction.

The book is the product of a Hastings Center project on synthetic biology that examined and debated the idea of synthesizing life. The first section of the book focuses on the human relationship to nature, with essays identifying basic questions about the ethics of making new organisms. The second section asks whether synthetic organisms, far from being morally troubling, might actually be intrinsically valuable. The last section concerns values and public policywhether and how intrinsic moral objections to synthetic biology might be integrated into policy-making and public discourse.

Gregory Kaebnick is research scholar at The Hastings Center and editor of the Hastings Center Report. Thomas Murray is President Emeritus of the Center and a senior research scholar. Kaebnick and Murray were principal investigators on two Hastings Center projects on synthetic biology.

"Synthetic biology is a hot topic and deserves ethical scrutiny, and this is one of the first volumes that attempts it," says Dale Jamieson, Director of Environmental Studies, New York University and author of Ethics and the Environment.

Jonathan D. Moreno, David and Lyn Silfen University Professor, University of Pennsylvania, calls the book "as innovative as synthetic biology itself."

Other contributors to the book are John Basl, assistant professor of philosophy at Bowling Green State University; Mark A. Bedau, professor of philosophy and humanities at Reed College; Joachim Boldt, assistant professor of medical ethics and the history of medicine at Freiburg University in Germany; John H. Evans, professor of sociology at the University of California, San Diego; Bruce Jennings, senior advisor at The Hastings Center and director of bioethics at the Center for Humans and Nature; Ben Larson, of the National Institutes of Health; Andrew Lustig, the inaugural holder of the Holmes Rolston III Chair in Religion and Science at Davidson College; Jon Mandle, professor of philosophy at University at Albany; Christopher J. Preston, philosophy teacher at the University of Montana; and Ronald Sandler, associate professor of philosophy and director of the Ethics Institute at Northeastern University.


'/>"/>

Contact: Susan Gilbert
gilberts@thehastingscenter.org
845-424-4040 x244
The Hastings Center
Source:Eurekalert

Related biology news :

1. MIT and Wilson Center receive NSF grant to develop synthetic biology research agenda
2. Synthetic biology research community grows significantly
3. Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies
4. Predictability: The brass ring for synthetic biology
5. Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
6. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
7. Developing microbial cell factories by employing synthetic small regulatory RNAs
8. Oscillating gel gives synthetic materials the ability to speak
9. Synthetic and biological nanoparticles combined to produce new metamaterials
10. New report finds increase in media coverage of synthetic biology
11. Synthetic fuel could eliminate US need for crude oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: